CTSO vs. SNWV, DRTS, NYXH, SMTI, CATX, BWAY, TCMD, NVRO, STIM, and SGHT
Should you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), Perspective Therapeutics (CATX), Brainsway (BWAY), Tactile Systems Technology (TCMD), Nevro (NVRO), Neuronetics (STIM), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.
Cytosorbents vs. Its Competitors
Cytosorbents (NASDAQ:CTSO) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.
Cytosorbents has a net margin of -41.77% compared to Sanuwave Health's net margin of -89.86%. Sanuwave Health's return on equity of 0.00% beat Cytosorbents' return on equity.
Cytosorbents currently has a consensus price target of $5.50, suggesting a potential upside of 433.98%. Given Cytosorbents' stronger consensus rating and higher probable upside, analysts plainly believe Cytosorbents is more favorable than Sanuwave Health.
In the previous week, Cytosorbents and Cytosorbents both had 1 articles in the media. Cytosorbents' average media sentiment score of 0.59 beat Sanuwave Health's score of 0.00 indicating that Cytosorbents is being referred to more favorably in the media.
Cytosorbents has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks.
32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 7.3% of Cytosorbents shares are held by insiders. Comparatively, 14.9% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Cytosorbents has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Sanuwave Health has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500.
Summary
Cytosorbents beats Sanuwave Health on 11 of the 16 factors compared between the two stocks.
Get Cytosorbents News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cytosorbents Competitors List
Related Companies and Tools
This page (NASDAQ:CTSO) was last updated on 7/19/2025 by MarketBeat.com Staff
Free CTSO Stock Alerts